These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8403779)

  • 1. A novel recombinant adenovirus vector expressing a flavivirus non-structural protein protects against lethal flavivirus challenge.
    Jacobs SC
    Clin Sci (Lond); 1993 Aug; 85(2):117-22. PubMed ID: 8403779
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice.
    Khoretonenko MV; Vorovitch MF; Zakharova LG; Pashvykina GV; Ovsyannikova NV; Stephenson JR; Timofeev AV; Altstein AD; Shneider AM
    Immunol Lett; 2003 Dec; 90(2-3):161-3. PubMed ID: 14687719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein.
    Timofeev AV; Ozherelkov SV; Pronin AV; Deeva AV; Karganova GG; Elbert LB; Stephenson JR
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():689-95. PubMed ID: 9568962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tick-borne encephalitis virus NS3 gene expression does not protect mice from homologous viral challenge.
    Morozova OV; Maksimova TG; Bakhvalova VN
    Viral Immunol; 1999; 12(4):277-80. PubMed ID: 10630787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis].
    Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic immunization against tick-borne encephalitis virus].
    Mitrofanova EE; Bakhvalova VN; Dobrikova EIu; Pap VA; Morozova OV
    Mol Biol (Mosk); 1997; 31(3):403-6. PubMed ID: 9297083
    [No Abstract]   [Full Text] [Related]  

  • 7. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A recombinant adenovirus expressing the NS1 nonstructural protein of tick-borne encephalitis virus: some characteristics of the immunologic basis of antiviral action].
    Timofeev AV; Ozherelkov SV; Pronin AV; Deeva AV; Elbert LB; Stefenson JR
    Vopr Virusol; 1997; 42(5):219-22. PubMed ID: 9424847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model.
    Volpina OM; Volkova TD; Koroev DO; Ivanov VT; Ozherelkov SV; Khoretonenko MV; Vorovitch MF; Stephenson JR; Timofeev AV
    Virus Res; 2005 Sep; 112(1-2):95-9. PubMed ID: 16022903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1.
    Jacobs SC; Stephenson JR; Wilkinson GW
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2399-402. PubMed ID: 8077939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilisation of ISA Reverse Genetics and Large-Scale Random Codon Re-Encoding to Produce Attenuated Strains of Tick-Borne Encephalitis Virus within Days.
    de Fabritus L; Nougairède A; Aubry F; Gould EA; de Lamballerie X
    PLoS One; 2016; 11(8):e0159564. PubMed ID: 27548676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model.
    Morris-Downes MM; Sheahan BJ; Fleeton MN; Liljeström P; Reid HW; Atkins GJ
    Vaccine; 2001 Jul; 19(28-29):3877-84. PubMed ID: 11427261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant vaccinia virus and a bacterial plasmid both expressing TBE virus non-structural NS1 protein.
    Aleshin SE; Timofeev AV; Khoretonenko MV; Zakharova LG; Pashvykina GV; Stephenson JR; Shneider AM; Altstein AD
    BMC Microbiol; 2005 Aug; 5():45. PubMed ID: 16076390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
    Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
    J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and Characterization of a Chimeric Tick-Borne Encephalitis Virus Attenuated Strain ChinTBEV.
    Wang HJ; Li XF; Qin CF
    Methods Mol Biol; 2016; 1403():285-93. PubMed ID: 27076137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model.
    Jacobs SC; Stephenson JR; Wilkinson GW
    J Virol; 1992 Apr; 66(4):2086-95. PubMed ID: 1532212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of humoral immunity in post-vaccination resistance of mice to tick-borne encephalitis].
    Nikonova AN; Rozhkova LV; Sokolova ED
    Tr Inst Im Pastera; 1989; 65():84-90. PubMed ID: 2560848
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein.
    Kreil TR; Maier E; Fraiss S; Eibl MM
    J Virol; 1998 Apr; 72(4):3076-81. PubMed ID: 9525632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.